LEADER 01342nam0 22003133i 450 
001 VAN00131102
005 20240806100833.303
010   $a978-36-625-3268-3
017 70$2N$a978-3-662-53270-6
100   $a20201007d2017       |0itac50      ba
101   $aeng
102   $aDE
105   $a||||    |||||
200 1 $aPercutaneous Penetration Enhancers Drug Penetration Into/Through the Skin$eMethodology and General Considerations$fNina Dragicevic, Howard I. Maibach editors
210   $aHeidelberg$cSpringer$d2017
215   $axvi, 414 p.$d24 cm
620   $aDE$dHeidelberg$3VANL000282
702  1$aDragicevic$bNina$3VANV104833
702  1$aMaibach$bHoward I.$3VANV086416
712   $aSpringer <editore>$3VANV108073$4650
790  1$aMaibach, Howard$zMaibach, Howard I.$3VANV237496
801   $aIT$bSOL$c20241213$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-662-53270-6$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN00131102
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 7135                      $e15EB 7135              20201007            
996   $aPercutaneous Penetration Enhancers Drug Penetration Into$91758009
997   $aUNICAMPANIA